A clinical trial involving Irish patients newly diagnosed with multiple myeloma has found that a new treatment option is highly effective.

Irish patients with blood cancer are the first worldwide to take part in a new drug trial to develop more effective treatment for multiple myeloma, a potentially fatal condition.